Astronics (ATRO) Q4 1999 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 1999 earnings summary
5 Nov, 2026Executive summary
Record 1999 sales of $50.637M and net income of $4.795M; diluted EPS reached $0.81, with 22 consecutive quarterly sales increases and 23 consecutive quarterly earnings increases on a trailing-12-month basis.
Shipments rose 10% and earnings 11%; year-end backlog exceeded $40M, supporting expectations for significantly higher 2000 shipments and strong earnings.
Financial highlights
Net sales increased 9.9% to $50.637M; net income rose 11.4% to $4.795M from $4.304M, and diluted EPS advanced to $0.81 from $0.73.
Operating income was $7.189M, up 1.3%; gross margin fell to 28.7% from 32.3%, reflecting product mix and higher F-16 program costs.
Operating cash flow reached $10.080M; cash flow per share was $1.70.
Outlook and guidance
2000 shipments were expected to reach approximately $70M, with strong earnings accompanying the sales growth.
F-16 NVIS shipments were expected to rise to approximately $16M annually, with the program extending into 2002; $27M was in program backlog.
MaxEL lamp sales were up 300% in 1999 and were expected to double in 2000.
Latest events from Astronics
- Record Q3 results and backlog support 2027 growth despite supply and timing risks.ATRO
Q3 2026 - Record growth led by F-16 demand; 2001 sales target exceeded $85M.ATRO
Q4 2000 - Record 2001 results met weakening demand as F-16 production neared its end.ATRO
Q4 2001 - F-16 sales faded, but stable margins and the JSF award shaped the next growth phase.ATRO
Q4 2002 - F-16 completion pressured 2003 results, while new design wins built a growth pipeline.ATRO
Q4 2003 - Higher development spending drove a 2004 loss as backlog and AES set up 2005 growth.ATRO
Q4 2004 - FY05 sales surged 117%; $95.1M backlog supports growth, tempered by certification risks.ATRO
Q4 2005 - Strong FY06 growth and FY07 outlook, tempered by restatements and control weaknesses.ATRO
Q4 2006 - Sales grew, but Eclipse charges cut FY08 earnings as DME reshaped the FY09 outlook.ATRO
Q4 2008